The production of customized dermocosmetics based on genetic analysis. The production of autologous cells and their derivatives, such as exosomes and growth factors or vascular stromal fraction, for cellular and non-cellular treatments in both dermatological and cosmetic surgery fields: more specifically, dermatological treatments, such as vitiligo and psoriasis or hair loss treatments, anti-aging treatments and thus wrinkle or scar treatments and the production of customized dermocosmetics. The company may also carry out all commercial or other activities related to the company's purpose in Switzerland and abroad. This also includes investments in securities and real estate, the acquisition of participations in companies and enterprises, participation in consortia and groupings.